Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Breast Neoplasms 4 Oropharyngeal Neoplasms 2 Motor Activity 2 Brain Neoplasms 2 Uveal Melanoma 1 Suicidal Ideation 1 Stomach Ulcer 1 Stomach Neoplasms 1 Skin Cancer Face 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Parotid Neoplasms 1 Mouth Neoplasms 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Li-Fraumeni Syndrome 1 Hyperandrogenism 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Hamartoma Syndrome, Multiple 1 Glioblastoma 1 Gastrointestinal Hemorrhage 1 Gastrointestinal Diseases 1 Gastritis 1 Disability Physical 1 Depression 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Carcinoma in Situ 1

Interventions

Cisplatin 258 Radiotherapy 193 Cetuximab 151 pembrolizumab 123 Docetaxel 97 Fluorouracil 92 Carboplatin 80 Paclitaxel 78 Radiotherapy, Intensity-Modulated 72 Surveys and Questionnaires 46 Nivolumab 42 Drug Therapy 34 Radiation 33 Blood Specimen Collection 27 Erlotinib Hydrochloride 26 Gemcitabine 25 Immunohistochemistry 22 Gefitinib 22 Cyclophosphamide 22 Surgical Procedures, Operative 21 Standard of Care 20 durvalumab 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 19 Radiosurgery 17 Capecitabine 17 Chemotherapy, Adjuvant 16 Celecoxib 16 Biopsy 16 atezolizumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Physical Examination × Clear all

NCT03163797 2017-07-02

PETMROPSCC

Chang Gung Memorial Hospital

Head and Neck Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡